1. Adjuvant chemotherapy following stereotactic body radiotherapy for early stage non-small-cell lung cancer is associated with lower overall: A National Cancer Database Analysis. (April 2019) Authors: Foster, Corey C.; Rusthoven, Chad G.; Sher, David J.; Feldman, Lawrence; Pasquinelli, Mary; Spiotto, Michael T.; Koshy, Matthew Journal: Lung cancer Issue: Volume 130(2019) Page Start: 162 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Corrigendum to "Adjuvant chemotherapy following stereotactic body radiotherapy for early stage non-small-cell lung cancer is associated with lower overall survival: A National Cancer Database Analysis" [Lung Cancer, Volume 130 (April) (2019) 162–168]. (June 2019) Authors: Foster, Corey C.; Rusthoven, Chad G.; Sher, David J.; Feldman, Lawrence; Pasquinelli, Mary; Spiotto, Michael T.; Koshy, Matthew Journal: Lung cancer Issue: Volume 132(2019) Page Start: 159 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Definition, Biology, and History of Oligometastatic and Oligoprogressive Disease. Issue 2 (March 2020) Authors: Foster, Corey C.; Pitroda, Sean P.; Weichselbaum, Ralph R. Journal: Cancer journal Issue: Volume 26:Issue 2(2020) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Definitive chemoradiation for locally-advanced oral cavity cancer: A 20-year experience. (May 2018) Authors: Foster, Corey C.; Melotek, James M.; Brisson, Ryan J.; Seiwert, Tanguy Y.; Cohen, Ezra E.W.; Stenson, Kerstin M.; Blair, Elizabeth A.; Portugal, Louis; Gooi, Zhen; Agrawal, Nishant; Vokes, Everett E.; Haraf, Daniel J. Journal: Oral oncology Issue: Volume 80(2018) Page Start: 16 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. Immune‐related adverse events are associated with improved response, progression‐free survival, and overall survival for patients with head and neck cancer receiving immune checkpoint inhibitors. Issue 24 (21st September 2021) Authors: Foster, Corey C.; Couey, Marcus A.; Kochanny, Sara E.; Khattri, Arun; Acharya, Rajesh K.; Tan, Yi‐Hung Carol; Brisson, Ryan J.; Leidner, Rom S.; Seiwert, Tanguy Y. Journal: Cancer Issue: Volume 127:Issue 24(2021) Page Start: 4565 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. Oligometastatic prostate cancer: Reality or figment of imagination?. Issue 3 (6th December 2018) Authors: Foster, Corey C.; Weichselbaum, Ralph R.; Pitroda, Sean P. Journal: Cancer Issue: Volume 125:Issue 3(2019) Page Start: 340 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. Reply to "Guarantee‐time bias in studies on the relationship between immune‐related adverse events and antitumor activity". Issue 13 (22nd April 2022) Authors: Foster, Corey C.; Seiwert, Tanguy Y. Journal: Cancer Issue: Volume 128:Issue 13(2022) Page Start: 2551 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗